Gore, S D <br/><br/>
A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Nov 1998 
 - 2677-89 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Bone Marrow--drug effects<br/>DNA Topoisomerases, Type I--metabolism<br/>Female<br/>Humans<br/>Leukocyte Count--drug effects<br/>Male<br/>Middle Aged<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>Risk Factors<br/>Topoisomerase I Inhibitors<br/>Topotecan--adverse effects<br/>Treatment Outcome